Krishna Institute of Medical Sciences Intrinsic Value
Krishna Institute of Medical Sciences (KIMS) median intrinsic value is ₹319.88 from 9 valuation models (range ₹243–₹778), vs current price ₹809.85 — -60.5% downside (Trading Above Calculated Value), margin of safety -100.0%. Check Krishna Institute of Medical S market cap to track the company's total market size over time.
KIMS Valuation Methods Summary — DCF, Graham Number & P/E
Krishna Institute of Medical Sciences intrinsic value across 9 models vs current price ₹809.85 — upside/downside and value range per method. For current market price and key ratios, visit KIMS share price screener.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹242.95 | ₹194.36 - ₹291.54 | -70.0% | EPS: ₹4.24, Sector P/E: 12x |
| Book Value Method | asset | ₹319.88 | ₹287.89 - ₹351.87 | -60.5% | Book Value/Share: ₹319.88, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹434.80 | ₹391.32 - ₹478.28 | -46.3% | Revenue/Share: ₹543.50, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹624.00 | ₹561.60 - ₹686.40 | -22.9% | EBITDA: ₹832.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹777.51 | ₹622.01 - ₹933.01 | -4.0% | CF Growth: 12.1%, Discount: 15% |
| PEG Ratio Method | growth | ₹242.95 | ₹218.66 - ₹267.25 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹242.95 | ₹218.66 - ₹267.25 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹404.93 | ₹364.44 - ₹445.42 | -50.0% | ROE: 5.2%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹242.95 | ₹218.66 - ₹267.25 | -70.0% | EPS: ₹4.24, BVPS: ₹319.88 |
KIMS Intrinsic Value vs Market Price — All Valuation Models
Krishna Institute of Medical Sciences fair value range ₹243–₹778 vs current market price ₹809.85 across 9 valuation models. See Krishna Institute of Medical S P/B valuation to compare market price against book value per share.
KIMS Intrinsic Value Analysis — Undervalued or Overvalued?
Krishna Institute of Medical Sciences median intrinsic value ₹319.88, current price ₹809.85 — Trading Above Calculated Value by 60.5%, margin of safety -100.0%.
What is the intrinsic value of KIMS?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Krishna Institute of Medical Sciences (KIMS) is ₹319.88 (median value). With the current market price of ₹809.85, this represents a -60.5% variance from our estimated fair value.
The valuation range spans from ₹242.95 to ₹777.51, indicating ₹242.95 - ₹777.51.
Is KIMS undervalued or overvalued?
Based on our multi-method analysis, Krishna Institute of Medical Sciences (KIMS) appears to be trading above calculated value by approximately 60.5%.
KIMS Financial Health — Key Ratios vs Industry Benchmarks
Krishna Institute of Medical Sciences financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.24 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | 5.2% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 18.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.56x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
KIMS Cash Flow Quality — Operating & Free Cash Flow
Krishna Institute of Medical Sciences operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹511 Cr | ₹-215 Cr | Positive Operating Cash Flow | 6/10 |
| March 2025 | ₹582 Cr | ₹24 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹521 Cr | ₹145 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹432 Cr | ₹224 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹324 Cr | ₹118 Cr | Positive Free Cash Flow | 7/10 |